Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD‐REIN cohort study-Reference-Cited by-同舟云学术

Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD‐REIN cohort study

Published:2021-01-19 Issue:7 Volume:87 Page:2967-2976
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Liabeuf Sophie¹²^ORCID,Lambert Oriane³,Metzger Marie³,Hamroun Aghiles³,Laville Maurice⁴⁵,Laville Solène M.³^ORCID,Frimat Luc⁶⁷,Pecoits‐Filho Roberto⁸,Fouque Denis⁹,Massy Ziad A.³,Jacquelinet Christian³¹⁰,Stengel Bénédicte³,

Affiliation:

1. Department of Clinical Pharmacology Amiens University Hospital Amiens France

2. Laboratory, EA7517 University of Picardie Jules Verne Amiens Amiens France

3. Centre for Research in Epidemiology and Population Health (CESP), Paris‐Saclay University Paris Sud University, Versailles Saint Quentin University, INSERM France

4. Nephrology Department Lyon Sud Hospital Pierre Benite France

5. Lyon University, INSERM U1060 CarMeN Pierre Benite France

6. Nephrology Department Nancy University Hospital Vandoeuvre‐lès‐Nancy France

7. Laboratory, EA4360 Lorraine University Nancy France

8. Arbor Research Collaborative for Health Ann Arbor Michigan USA

9. Nephrology Department, Centre Hospitalier Lyon Sud Université de Lyon Carmen Pierre‐Bénite France

10. Biomedecine Agency Saint Denis La Plaine France

Funder

Agence Nationale de la Recherche

Agence Nationale de Sécurité du Médicament et des Produits de Santé

Amgen

AstraZeneca